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Stat6-Independent GATA-3 Autoactivation Directs
IL-4-Independent Th2 Development and Commitment
initial source of IL-4 (Yoshimoto et al., 1995a, 1995b;
Bendelac et al., 1996), but several studies showed that
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activates the IL-5 promoter (Zhang et al., 1997), andGermany
GATA-3-dependent enhancer activity has been found
within several regions surrounding the IL-4 gene (Ranga-
nath et al., 1998). GATA-3 expression by retrovirus inSummary
developing Th1 cells blocks IL-12 receptor expression
and prevents Th1 development independently of theThe initial source of IL-4-inducing Th2 development
induction of IL-4 (Ouyang et al., 1998). c-Maf directlyand the mechanism of stable Th2 commitment remain
augments IL-4 promoter activity through cooperativeobscure. We found the reduced level of IL-4 production
interactions with Nip-45, NF-AT (Ho et al., 1996, 1998),in Stat6-deficient T cells to be significantly higher than
and JunB (Rincon et al., 1997b). Transgenic c-Maf over-in Th1 controls. Using a novel cell surface affinity ma-
expression increases IL-4 and alters the isotype patternstrix technique, we found that IL-4-secreting Stat6-defi-
of antibody with increased IgE (Ho et al., 1998), andcient T cells stably expressed GATA-3 and Th2 pheno-
c-Maf-deficient T cells show a selective reduction intype. Introducing GATA-3 into Stat6-deficient T cells
IL-4 but not other Th2-specific cytokines (Kim et al.,completely restored Th2 development, inducing c-Maf,
1999a, 1999b).Th2-specific DNase I hypersensitive sites in the IL-4
While these studies have added to our understandinglocus, and Th2 cytokine expression. The fact that
of cytokine gene regulation, much less is known aboutGATA-3 fully reconstitutes Th2 development in Stat6-
how GATA-3 and c-Maf expression themselves are regu-deficient T cells indicates it is a master switch in Th2
lated. In naive T cells, these factors are expressed atdevelopment. Finally, GATA-3 exerts Stat6-indepen-
low levels, which increase over the first week of Th2dent autoactivation, creating a feedback pathway sta-
development (Ho et al., 1996; Zhang et al., 1997; Zhengbilizing Th2 commitment.
and Flavell, 1997; Ouyang et al., 1998). The pathways
and controlling elements directing their Th2-specific
Introduction expression have not been reported. It is known that
IL-4 can induce early expression of GATA-3 in a Stat6-
IL-4 signaling during primary T cell activation can initiate dependent manner and that IL-12 can inhibit GATA-3
an efficient cascade of Th2 development (Le Gros et al., expression in a Stat4-dependent manner (Ouyang et al.,
1990). By analogy with macrophage production of IL- 1998). However, the hierarchy of control between Stat6,
12 directing Th1 development (Hsieh et al., 1993), an GATA-3, and c-Maf has not been extensively analyzed.
initial source of IL-4 directing Th2 development has been Importantly, the phenotype of developing Th2 cells be-
presumed to involve innate immune cells, perhaps in comes increasingly stable over time (Szabo et al., 1995;
response to a pathogen, although the identity of this Murphy et al., 1996) and independent of extrinsic factors
source has been elusive (Coffman and von der Weid, (i.e., cytokines such as IL-4) for maintaining Th2 cytokine
1997). Several innate immune cells secrete IL-4, but expression (Huang et al., 1997). While the factor inde-
none appear necessary for Th2 development. For exam- pendence of the Th2 phenotype is an important aspect
ple, NK1.11 T cells, which rapidly secrete IL-4 following of T helper memory, the molecular basis for this stabi-
in vivo activation, had been an ideal candidate for an lized phenotype is not clear.
Th2 development has been considered to be essen-
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Figure 1. Stat6-Deficient T Cells Produce IL-4
at Significantly Higher Frequency than Wild-
Type Th1 Cells
(A and B) Wild-type or Stat6-deficient
DO11.10 splenocytes were activated as indi-
cated in the Experimental Procedures. Cells
were treated with IL-12 and anti-IL-4 (left pan-
els); anti-IL-12, anti-IFNg, and anti-IL-4 (mid-
dle panels); or anti-IL-12, anti-IFNg, and IL-4
(right panels) as described in the Experimen-
tal Procedures. After 6 days, cells were har-
vested and restimulated for 4 hr with PMA
and ionomycin for intracellular IL-4 (A) or in-
tracellular IFNg (B) staining as described in
the Experimental Procedures. Analysis gates
were set on CD41 lymphocytes according to
light scatter and staining with CD4-APC. The
number in the upper right quadrant is the per-
centage of IL-4-positive cells in the gated
CD41 population. Data shown are represen-
tative of four similar experiments.
(C) Splenocytes from unimmunized DO11.10
Stat6-deficient mice were purified for CD4 ex-
pression and either Mel-14hi or Mel-14lo sur-
face phenotype. Purified T cells were either
activated immediately (ªWithout Primingº)
with PMA/ionomycin and assayed for intra-
cellular IL-4 staining or were primed using
OVA/APC and anti-IL-12, anti-IFNg, and anti-
IL-4 as described in the Experimental Proce-
dures for 6 days (ªWith Primingº) and then
reactivated with PMA/ionomycin and as-
sayed for intracellular IL-4 staining. As a con-
trol for the intracellular IL-4 staining, wild-
type Th2 cells were stained in parallel (data
not shown). Analysis gates were set on CD41
T cells. The number in the upper right quad-
rant is the percentage of IL-4-positive cells
in the gated CD41 population. Data shown
are representative of two similar experiments.
double-knockout mice suggested that Th2 development not produce IL-4 or IL-13 (Rissoan et al., 1999). Although
the mechanisms for these effects are completely un-could be partly Stat6 independent (Dent et al., 1998).
Bcl-6, a zinc finger transcriptional repressor, binds sites known, these results challenge the concept that IL-4
and Stat6 activation are necessary for Th2 development.recognized by STAT factors. Bcl-6 disruption produced
an inflammatory disorder characterized by increased In summary, while in terms of molecular mechanism,
IL-4 is the best understood stimulus for Th2 develop-type 2 cytokine production, suggesting enhanced Th2
development (Dent et al., 1998). Surprisingly, this pheno- ment, several important issues remain unresolved. First,
the initiating source of IL-4 has been long sought but hastype persisted even when the Bcl-6 deficiency was
crossed onto the Stat6-deficient background. This result not been identified. Second, indirect evidence suggests
that Th2 development can be independent of both IL-4suggests that some component of Th2 development or
Th2 cytokine production is Stat6 independent. and Stat6. Finally, current models cannot explain how
Th2 cells acquire phenotype stability and independenceA second observation further challenges the reigning
dogma that an initial source of IL-4 is required to induce from extrinsic factors (i.e., IL-4) in maintaining the Th2
phenotype.Th2 development (Rissoan et al., 1999). Two populations
of human dendritic cells have been described with diver- This study was prompted by our observation of persis-
tent IL-4 production in Stat6-deficient T cells. To analyzegent effects on Th1/Th2 development. Mature myeloid
dendritic cells (DC1), derived from immature myeloid this phenomenon, we developed a novel sorting tech-
nique allowing cell purification based upon IL-4 secre-dendritic cells (pDC1) stimulated with CD40 ligand, can
produce IL-12 and enhance Th1 development, not unex- tion and applied this approach to Th2 development in
Stat6-deficient cells. This technology had been devel-pectedly. However, a population termed DC2, derived
from CD41CD32CD11c2 plasmacytoid cells treated with oped originally to isolate cells according to specific se-
cretion of antibodies or cytokines (Manz et al., 1995)IL-3 and CD40L stimulation, enhanced Th2 development
when IL-4 was neutralized, even though these cells do and has been used successfully so far for the isolation
Stat6-Independent Th2 Development
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Figure 2. Cellular Affinity Matrix Technology
Allows Detection of Secreted IL-4 on Viable
Cells with the Sensitivity and Specificity of
Intracellular Staining
(A) DO11.10 splenocytes were stimulated
with OVA peptide, IL-4, anti-IL-12, and anti-
IFNg for 6 days and restimulated with fresh
APC and peptide as described in the Experi-
mental Procedures. After 2.5 hr, all cells were
labeled with the IL-4-specific capture matrix,
a bispecific conjugate of anti-mCD45 and
anti-mIL-4 antibodies, then permitted to se-
crete cytokines at 378C for 15 min (left panel).
As controls, after labeling with IL-4 capture
matrix, cells were either put on ice immedi-
ately to prevent secretion (right panel) or incu-
bated with recombinant murine IL-4 (150 ng/
ml) on ice for 10 min (middle panel). IL-4 cap-
tured on the cell surface was then detected
by anti-IL-4-PE antibody. The DO11.10 TCR
clonotype was detected by Cy5-KJ1-26 anti-
body. The frequencies given in the upper
quadrants of the dot plots indicate the per-
centage of cells positive for secreted IL-4
within the KJ1-26-positive or -negative popu-
lation.
(B) The staining of secreted IL-4 correlates
with the staining of intracellular IL-4. Immedi-
ately after the IL-4 secretion assay shown in
(A) (left panel), the cells were fixed and further
stained for the transgenic TCR identified by
the clonotypic mAb KJ1-26-biotin and then
streptavidin-PerCP. Intracellular IL-4 was
stained with a third anti-IL-4 mAb (11B11),
which was coupled to digoxigenin (Dig). To
verify that staining of intracellular IL-4 identi-
fied intracellular IL-4 and not IL-4 bound to
the cell surface, the staining of intracellular
IL-4 was performed either in PBS/BSA/azide
containing 0.5% saponin to permeabilize the
cell membrane to achieve intracellular stain-
ing (upper panels) or in PBS/BSA/azide
without saponin, which leaves the cell membrane intact (lower panels). In both cases, the background of the staining for intracellular IL-4
was controlled by using the secondary Cy5-conjugated antibody only (anti-Dig control) (right panels). Analysis gates were set on KJ1-261
lymphocytes.
of murine Th cells secreting IFNg or IL-2 (Assenmacher of Stat6-deficient T cells were consistently seen to pro-
et al., 1998) and the isolation of human Th cells secreting duce IL-4 under Th2-inducing conditions (Figure 1A,
IFNg upon antigenic challenge (Brosterhus et al., 1999). right panel), a significantly higher fraction than present
Here, we further developed this technology for isolation in Th1 control cultures. This level of IL-4 production was
of viable, murine IL-4-secreting cells, introducing bi- Stat6 independent but was also independent of other
specific antibody±antibody conjugates (anti-CD45±anti- IL-4-derived signals, since the same level was observed
IL-4) to anchor the affinity matrix on the cell surface. when T cells were primed in the absence of IL-4 (Figure
1A, middle panel). This level was similar between Stat6-
deficient T cells and wild-type T cells (compare FigureResults
1A, middle panels), suggesting that this IL-4/Stat6-inde-
pendent pathway occurs in normal T cells and not justStat6-Deficient T Cells Undergo Th2 Development
in genetically manipulated mice. In both wild-type andTo test the requirement of IL-4 signaling in IL-4 produc-
Stat6-deficient Th cells, we observed a high frequency oftion and Th2 development, we compared wild-type and
IFNg production (.90%) under Th1-inducing conditionsStat6-deficient T cells following primary activation for
(Figure 1B, left panels), which was reduced to 10% IFNg-production of IL-4 (Figure 1A) and IFNg (Figure 1B). Wild-
positive cells in neutralized conditions (Figure 1B, mid-type and Stat6-deficient splenocytes were activated by
dle panels). Addition of IL-4 at priming further reducedOVA under several conditions, and cytokine production
the frequency of IFNg-producing cells only in wild-typewas assessed on day 6 by intracellular staining after
(6%) but not in Stat6-deficient (12%) Th cells (FigurePMA/ionomycin restimulation. In Th2-inducing condi-
1B, right panels), further supporting the notion that IL-4tions, 39% of wild-type T cells produced IL-4 (Figure
does not influence the cytokine production of Stat6-1A, right panel), whereas in Th1 conditions only 2%
produced IL-4 (Figure 1A, left panel). Surprisingly, 7% deficient T cells.
Immunity
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Figure 3. IL-4 Production by Stat6-Deficient T Cells Is a Stably Maintained Phenotype and Approaches Levels of Wild-Type Th2 Cells
(A) Purification of IL-4-secreting Stat6-deficient T cells using the cellular affinity matrix technology and magnetic cell separation. Stat6-deficient
T cells as described in Figure 1 were used for sorting IL-4-secreting cells. On day 7, the cells were harvested, stimulated with PMA/ionomycin
for 2.5 hr, and an IL-4 secretion assay was performed as described in the Experimental Procedures. The cells were allowed to secrete IL-4
for 30 min and stained for surface-captured IL-4 by PE-anti-IL-4 antibody and APC-anti-CD4, as shown in the top panel. Cells were further
labeled with anti-PE-antibody conjugated to magnetic beads and applied for MACS sorting. After three rounds of purification, sorted IL-4-
positive cells (lower right panel) and IL-4-negative cells (lower left panel) were obtained.
(B and C) Stable maintenance of IL-4 production by Stat6-deficient T cells. Sorted IL-4-positive and IL-4-negative cells as described in (A)
were placed into culture for 6 days and restimulated by OVA and APC for continuing passage. As a control, wild-type (WT) Th2 cells (left
panel) were maintained in parallel under the same conditions. On day 7, resting T cells from all cultures were restimulated again by OVA and
APC. Forty-eight hours later, supernatants were harvested for analysis of IL-4 by ELISA (C). Data shown are the mean 6 SEM of three
independent measures. Three days after activation, IL-4 production was analyzed by intracellular cytokine staining (B) after PMA/ionomycin
stimulation. Analysis gates were set on lymphocytes according to light scatter after APC-CD4 and intracellular PE-IL-4 staining. Controls for
PE-IL-4 staining were determined using a PE-isotype control. Similar data were obtained in two independent experiments. Similar results
were also obtained in independent experiments after cells were restimulated and passed in culture for several rounds.
The IL-4-producing Stat6-deficient T cells are not de- the IL-4 produced by Stat6-deficient T cells was due to
GATA-3 expression that is IL-4- and Stat6-independentrived from a preactivated memory population, since they
require priming in order to acquire the capacity to pro- but IL-12-repressible. To test this, we needed to sepa-
rate Stat6-deficient T cells into IL-4-producing andduce IL-4. We separated T cells from unimmunized
Stat6-deficient DO11.10 mice into CD41Mel-14hi and -nonproducing populations. However, intracellular cyto-
kine staining requires cell permeabilization and resultsCD41Mel-14lo populations for direct comparison (Figure
1C). In both the naive (Mel-14hi) and previously activated in cell death, preventing subsequent developmental
analysis. Thus, we needed a novel method by which to(Mel-14lo) populations, IL-4 was produced by similar
numbers of T cells, and this production required in vitro isolate T cells on the basis of their cytokine secretion
that would have the analytic capacity of intracellularpriming (Figure 1C, compare upper to lower panels).
Importantly, this is a population of conventional T cells. staining, yet leave cells viable.
For this, we had established earlier a sorting techniqueFirst, they are conventional ab T cells from DO11.10
TCR-transgenic mice and not restricted to CD1 (Murphy based on the surface capture of secreted cytokines. In
further developing this technique, we now generated aet al., 1990). Second, they are CD41 and are negative
for NK1.1 and DX5, a pan NK cell marker (data not bispecific antibody±antibody conjugate, binding to both
murine IL-4 and murine CD45, a highly abundant cellshown).
We previously had shown that GATA-3 expression is surface protein. Binding of this bispecific conjugate to
cell surfaces through interaction with CD45 produces aincreased by IL-4 through Stat6 and, importantly, re-
pressed by IL-12 through Stat4. Thus, we wondered if high-capacity surface matrix on T cells with high affinity
Stat6-Independent Th2 Development
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for IL-4. Following IL-4 secretion by the cells and surface
capture of secreted IL-4 by the matrix, a secondary
phycoerythrin (PE)-conjugated anti-IL-4 antibody is used
for cytometric detection and purification by high-gradient
magnetic field cell sorting (MACS), using phycoerythrin-
specific superparamagnetic microbeads. The specificity
of the technique was evaluated using wild-type Th2
cells, activated by OVA and non-IL-4-producing antigen-
presenting cells (APC) for 2.5 hr (Figure 2A). After 15
min of cytokine secretion in the presence of the affinity
matrix, captured IL-4 was detected by the PE-conju-
gated anti-IL-4. Secreted IL-4 was found only on anti-
gen-specific T cells, i.e., cells identified by the antibody
KJ1-26 (DO11.10 clonotype), excluding cross-contami-
nation of IL-4 to other cells (Figure 2A, left panel). Exoge-
nously added recombinant IL-4 revealed that all cells
had obtained a uniform and high capacity to bind IL-4
on the cell surface (Figure 2A, center panel). Preventing
the T cells from active secretion by incubating them
Figure 4. Stat6-Deficient IL-4-Producing T Cells Express High Lev-not at 378C but on ice blocked the appearance of IL-4-
els of GATA-3
secreting cells (Figure 2A, right panel). Finally, cytokine
(A) Sorted IL-4-producing Stat6-deficient T cells express other Th2
detection by the cellular affinity matrix technology corre- cytokines. T cells purified according to IL-4 secretion as described
lates very well with detection by intracellular immunoflu- in Figure 3 were activated and expanded twice with OVA and APC
orescence (Figure 2B), indicating no loss in sensitivity and stimulated by PMA/ionomycin for 4 hr for total RNA purification.
Two micrograms of total RNA was used for RNase protection analy-or specificity.
sis as described in the Experimental Procedures. Data presentedWe next used this technique to separate Stat6-defi-
for IL-4, IL-5, and IL-10 are a 16 hr exposure, and for IL-13, IL-2,cient T cells on the basis of their IL-4 production (Figure
IFNg, and L32, a 6 hr exposure.3). CD41 Stat6-deficient DO11.10 T cells were activated
(B) Stat6-deficient IL-4-producing T cells express high levels of
with OVA in the presence of anti-IFNg, anti-IL-12, and GATA-3. Wild-type or Stat6-deficient splenocytes were activated as
IL-4 and after 7 days were restimulated with PMA/iono- described in Figure 1. Cells were harvested on either day 2 or day
mycin and analyzed for IL-4 production (Figure 3). Con- 7 for total RNA preparation. Total RNA from Stat6-deficient T cells
sorted according to IL-4 secretion was prepared as described insistent with the results in Figure 1, 8% of the Stat6-
(A). Northern analysis was carried out using GATA-3, c-Maf, anddeficient T cells were positive for secreted IL-4 (Figure
GAPDH probes as described in Experimental Procedures.3A, upper panel). These cells were then subjected to
MACS, yielding populations of approximately 97% pure
IL-4-nonsecreting (Figure 3A, lower left panel) and 97%
wild-type controls, Stat6 may play some role in aug-
pure IL-4-secreting T cells (Figure 3A, lower right panel).
menting cytokine production in terminally differentiated
We first determined whether IL-4 production was sta-
Th2 cells. In summary, the IL-4 production phenotype
ble over time in these populations. The cells purified as
of T cells purified by IL-4 surface capture is stable overin Figure 3A were reactivated and repeatedly expanded
time, with positive cells remaining positive and negativewith antigen and APC on a weekly basis. After each
cells remaining negative for at least 8 weeks, suggest-passage, the T cells were activated with PMA/ionomycin
ing that the initial IL-4 production is not simply a randomand cytokine production was measured (Figure 3B).
event.After three passages, Stat6-deficient T cells that initially
had been sorted as IL-4 negative remained IL-4 nega-
GATA-3 Induces IL-4- and Stat6-Independenttive, subsequently showing less than 1.5% intracellularly
Th2 Developmentpositive cells (Figure 3B, right panel). Stat6-deficient
We next analyzed these two populations for expressionT cells, initially sorted as IL-4 positive, remained IL-4
of other Th2 cytokines by RNase protection (Figure 4A).positive, with 30% staining for intracellular IL-4, approxi-
The Stat6-deficient T cells sorted for positive IL-4 ex-mately half the frequency of wild-type Th2 cells, which
pression produced similar levels of IL-4 by RNase pro-had been cultured in parallel (Figure 3B, left and middle
tection as the wild-type Th2 controls, as expected frompanels). These results agree with IL-4 production mea-
the data above (Figure 3), whereas the cells sorted forsured by ELISA (Figure 3C). Stat6-deficient T cells ini-
IL-4-negative expression were negative by RNase pro-tially isolated as IL-4-negative cells produced extremely
tection as well. In addition, Stat6-deficient T cells sortedlow levels of IL-4, comparable to Th1 controls and un-
for positive IL-4 expression were also positive for IL-5sorted Stat6-deficient T cells. By contrast, Stat6-deficient
and IL-13 but lower in IL-10 expression than the Th2T cells, initially sorted as IL-4 positive, produced 50% of
controls. We further compared these populations ofwild-type Th2 IL-4 by ELISA. Therefore, the 7%±8% of
Stat6-deficient IL-4-secreting and IL-4-nonsecreting TStat6-deficient T cells that had produced IL-4 early on in
cells for expression of Th2-specific transcription factorsculture by and large had retained the capacity for IL-4
(Figure 4B). Previously, we had argued that IL-4 andproduction, while Stat6-deficient T cells that had been
Stat6 were required for induction of GATA-3 based onIL-4 negative at early times did not acquire the capacity
bulk analysis of Stat6-deficient T cells (Ouyang et al.,to express IL-4 later. Since the IL-4 produced by Stat6-
deficient T cells is approximately one-half of the Th2 1998). Surprisingly, Stat6-deficient T cells sorted for IL-4
Immunity
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Figure 5. GATA-3 Induces Stat6-Indepen-
dent Th2 Development
Wild-type or Stat6-deficient DO11.10 spleno-
cytes were activated by OVA peptide under
either Th1- or Th2-priming conditions. After
24 hr, cells were infected with either empty
retrovirus (GFP-RV) or a GATA-3-expressing
retrovirus (GATA3-RV), as described in the
Experimental Procedures. Cells were allowed
to develop until day 7 and purified by cell
sorting based on GFP expression, as pre-
viously described (Ouyang et al., 1998; Ran-
ganath et al., 1998). Purified cells were reacti-
vated using OVA and APC, expanded, and
supernatants were harvested 48 hr later. IL-4
(A) and IFNg (B) production were measured
by ELISA. Data represent the mean 6 SEM
of triplicate determinations. Similar data have
been obtained in six independent transfec-
tions. (C) GATA3 induces other Th2 cytokine
expression in Stat62/2 T cells. Sorted retrovi-
ral transfected T cells were expanded by OVA
and APC stimulation. On day 7, cells were
stimulated by PMA/ionomycin for 12 hr be-
fore total RNA was purified. Multicytokine ex-
pression was measured by RNase protection
assay as described in the Experimental Pro-
cedures.
secretion on day 7 had high GATA-3 expression, GATA-3 Gene Expression Involves Stat6-
Independent Autoactivationwhereas the non-IL-4-secreting Stat6-deficient T cells
were GATA-3 negative (Figure 4B, compare lanes 4 and In analyzing the cells in Figure 5, we confirmed retroviral
GATA-3 expression by Northern analysis, comparing en-5). Further, c-Maf was slightly elevated relative to the
IL-4-nonsecreting Stat6-deficient T cells. This result dogenous GATA-3 as an anticipated negative control.
In wild-type T cells infected with control retrovirus (GFP-suggested that GATA-3 and c-Maf may play a role in
the early IL-4 production and Th2 commitment of these RV) induced for Th2 development, only endogenous
GATA-3 was detected, as expected (Figure 6A, lane 7).Stat6-deficient T cells. Whether GATA-3 and c-Maf were
induced by some distinct factor or occurred by a sto- Likewise, in Stat6-deficient T cells infected with GFP-
RV and induced for Th1 development, neither retroviralchastic process is unclear, but the above results show
that GATA-3 and c-Maf may be responsible for the Stat6- GATA-3 nor endogenous GATA-3 was detected (Figure
6A, lane 5), also as expected. However, in GATA-3-independent Th2 development observed in these cells.
To test this, we used a bicistronic retrovirus to express infected T cells induced for Th1 development, we de-
tected not only retroviral GATA-3, but unexpectedly weGATA-3 in Stat6-deficient T cells or wild-type T cells as
a control (Figure 5). Expression of GATA-3 in Stat6- also detected endogenous GATA-3 (Figure 6A, lanes 2, 4,
and 6). Induction of endogenous GATA-3 occurred notdeficient T cells led to high IL-4 production, approxi-
mately half the Th2 control, and this was independent only in wild-type T cells (lane 2), but also in IL-4-deficient
(lane 4) and Stat6-deficient T cells (lane 6), which areof whether the T cells were treated under Th1- or Th2-
inducing conditions (Figure 5A). Further, GATA-3 ex- unable to induce GATA-3 in response to IL-4 (Ouyang et
al., 1998). To confirm these results, endogenous GATA-3pression in Stat6-deficient T cells reduced IFNg produc-
tion from Th1-induced T cells (Figure 5B), consistent was distinguished from retroviral GATA-3 not only by
size on Northerns (Figure 6A), but also by using probeswith previous data on GATA-3 expression in wild-type
T cells (Ouyang et al., 1998). We also examined other for the expression of the retroviral IRES and a probe to
the 39 UTR of GATA-3 to detect endogenous GATA-3Th2-specific cytokines by RNase protection (Figure 5C).
We find that Stat6-deficient GATA-3-transduced T cells, expression (data not shown), with similar results. Thus,
retroviral expression of GATA-3 appears to activate ex-primed both in Th1- and Th2-inducing conditions, also
expressed IL-5, IL-10, and IL-13 similarly to the wild- pression of the endogenous GATA-3 gene, even under
conditions that normally suppress the endogenous genetype Th2 control, while the IL-4 signal was somewhat
reduced, consistent with the ELISA results shown in (i.e., added IL-12 and anti-IL-4) and in cells lacking the
known signal for GATA-3 induction (i.e., IL-4 and Stat6).Figure 5A. These results suggest that Th2 development
is not directly dependent on IL-4 or Stat6 but rather is This suggests that GATA-3 participates in an autoactiva-
tion feedback loop that is independent of both IL-4 anddirectly controlled by the expression of GATA-3, which
can be augmented by these factors. Stat6. At this time, this autoactivation feedback loop
Stat6-Independent Th2 Development
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Figure 6. GATA-3 Exerts Stat6-Independent
Positive Autoactivation
(A) Autoactivation of endogenous GATA-3 by
retroviral GATA-3 in wild-type, IL-4-deficient,
and Stat6-deficient T cells. T cells from either
wild-type, IL-4-deficient, or Stat6-deficient
mice were infected with control retrovirus
(GFP-RV) or GATA-3-expressing retrovirus
(GATA3-RV) under Th1- or Th2-priming con-
ditions as described in the Experimental Pro-
cedures as indicated. Cells were purified by
cell sorting for GFP expression on day 7 and
expanded in vitro. After 7 days, T cells were
stimulated with PMA/ionomycin for 8 hr and
harvested for total RNA isolation. Northern
blots were probed with either GATA-3 cDNA
(upper panel) or GAPDH (lower panel), as pre-
viously described (Ouyang et al., 1998).
(B) Time course of GATA-3 and c-Maf induc-
tion during Th1 and Th2 differentiation. Wild-
type (WT) or Stat-6-deficient (Stat62/2) T cells
were activated under Th1- or Th2-inducing
conditions as indicated. On the indicated day
after primary T cell activation, cells were har-
vested, total RNA prepared, and Northern
analysis done as described in Figure 4B. For
day 9 samples, cells were restimulated at day
7 by OVA/APC for 48 hr before being har-
vested. Data are representative of two similar
experiments.
(C) Induction of c-Maf by GATA-3 is Stat6
independent. Retroviral infected wild-type
(WT) or Stat6-deficient (Stat62/2) T cells as described above were analyzed by Northern using a c-Maf probe or GAPDH probe, as described
in the Experimental Procedures. Data are representative of two similar experiments.
could either be a direct action of GATA-3 on its own Th2-Specific Chromatin Remodeling Is GATA-3
Dependent but Stat6 Independentpromoter/enhancer or could be mediated through in-
Several DNase I hypersensitive sites in the IL-4 geneduction of intermediate factors, perhaps such as c-Maf
were recently shown to be selectively acquired in Th2or other factors. In any case, this autoactivation loop is
but not Th1 T cells (Agarwal and Rao, 1998). Theseindependent of IL-4 and Stat6, which are the only factors
DNase I hypersensitive sites were absent in Stat6-defi-so far shown to induce GATA-3.
cient T cells, suggesting that Th2-specific chromatinThis result predicts a threshold for GATA-3 feedback
remodeling occurred by a mechanism involving Stat6.may exist that controls the stable switch to GATA-3
However, since the IL-4 expression, c-Maf induction,expression for maintenance of Th2 phenotype. If so,
and GATA-3 autoactivation described above were allGATA-3 induction might occur earlier than other Th2
GATA-3 dependent but occurred in Stat6-deficient Ttranscription factors during Th2 development. GATA-3
cells, we wondered whether Th2-specific sites in theinduction is barely evident on day 2 of primary activation
IL-4 gene might result from actions of GATA-3 rather(Figure 6B, lane 2) and markedly elevated by day 5 (lane
than directly from those of Stat6.4). By comparison, Th2-specific expression of c-Maf is
To test this, wild-type and Stat6-deficient T cells wereevident at approximately day 7 following primary T cell
infected either with GFP-RV or GATA-3-expressing ret-activation (Figure 6B, lanes 5 and 6) (Ouyang et al., 1998).
rovirus, purified, and allowed to develop, and DNase IThus, we examined c-Maf expression after infection of
hypersensitivity of the IL-4 locus was examined (Figure
Stat6-deficient T cells by GATA-3-expressing or control
7). As a control, we first confirmed the Th2-specific ac-
retrovirus (Figure 6C). GATA-3 expression in Stat6-defi- quisition of the reported DNase I hypersensitive sites in
cient T cells caused high levels of c-Maf expression even uninfected wild-type Th2 cells and their absence in
in Th1-inducing conditions (Figure 6C, lane 5), whereas Stat6-deficient cells (Figure 7A). Thus, the DNase I hy-
these conditions led to an absence of c-Maf expression persensitive sites II, III, and V developed in wild-type
with control virus (Figure 6C, lane 4). This result suggests Th2 cells (Figure 7A, lanes 2±5) but did not develop in
that the induction of GATA-3 can promote the expres- Stat6-deficient T cells activated in Th2-inducing condi-
sion of c-Maf expression independently of Stat6 during tions (Figure 7A, lanes 6±10), as described (Agarwal and
Th2 development, although this induction may either be Rao, 1998). However, we observed that DNase I hyper-
direct or through induction of intermediate factors. In sensitive sites II, III and V were each acquired in GATA-
addition, IL-4/Stat6 may be able to induce c-Maf expres- 3-infected Stat6-deficient T cells (Figure 7B, lanes 7±10)
sion independently of GATA-3, an issue that will require but not by control-infected Stat6-deficient cells (Figure
7B, lanes 2±5). The pattern of DNase I hypersensitivitydirect promoter analysis.
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Figure 7. GATA-3 Expression Generates Th2-Specific DNase I Hypersensitive Sites Independently of Stat6
(A) Wild-type (WT) or Stat6-deficient (Stat62/2) DO11.10 T cells were activated with OVA peptide under Th2-inducing conditions for 7 days.
Cells were expanded by anti-CD3 stimulation as described previously (Agarwal and Rao, 1998) for another week. DNase I hypersensitivity
analysis was performed as described in the Experimental Procedures. DNase concentrations used were 0, 10, 15, 20, and 35 U/ml.
(B) Stat6-deficient T cells primed under Th2-inducing conditions were infected with either GFP-RV or GATA3-RV and sort-purified for GFP
expression as described in Figure 5. Cells were activated by anti-CD3 for a week and examined for DNase I hypersensitive sites at the IL-4
locus as described (Agarwal and Rao, 1998). DNase concentrations used were 0, 10, 12, 15, and 35 U/ml.
in GATA-3-infected Stat6-deficient T cells is generally of cells secreting murine IL-4. First, instead of avidin-
anti-cytokine conjugates linked to the cell surface ofsimilar to those of the wild-type Th2 control, indicating
biotinylated cells, with the biotinylation causing heavythat the mechanism of chromatin remodeling giving rise
cell loss (Manz et al., 1995), we used a bispecific conju-to them is not strictly Stat6-dependent but is rather
gate of anti-IL-4 and anti-CD45 antibodies. Abundantdependent on a mechanism involving GATA-3.
CD45 expression on hematopoietic cells allows creation
of a high-density, high-affinity surface matrix on anyDiscussion
CD45-positive cell, specific for efficient capture of IL-4.
IL-4 secreted by cells coated with the matrix is boundA significant role for IL-4 in Th2 development was recog-
to the cell surface and detected by a second anti-IL-4nized early on in the analysis of the CD41 T cell subset
antibody, labeled to allow fluorescent detection and(Le Gros et al., 1990) and confirmed by in vitro experi-
magnetic separation (Figure 2). Importantly, there is nomentation (Hsieh et al., 1992). Analysis of IL-4- and
cross-contamination of the secreted IL-4 to non-IL-4-Stat6-deficient mice demonstrated reduced Th2 devel-
producing cells in the culture, and detection is as sensi-opment, strengthening the concept that IL-4 and Stat6
tive as standard intracellular staining. The present re-may be absolute requirements (Kopf et al., 1993; Kaplan
sults, in line with previous ones (Assenmacher et al.,et al., 1996a; Shimoda et al., 1996; Takeda et al., 1996).
1998), show that nearly all cytokine-secreting cells areThis idea has prompted vigorous attempts to define the
detected by both intracellular staining and cellular affin-
initial IL-4 source that initiates the Th2 cascade, with
ity matrix technologies.
non-T cells (Yoshimoto et al., 1995a, 1995b; Bendelac Here, we used this technique to purify Stat6-deficient
et al., 1996) and cytokines (Rincon et al., 1997a) being T cells into pure populations based on their IL-4 secre-
considered as candidates. tion. Stat6-deficient T cells secreting IL-4 on day 7 main-
In contrast, our previous data suggested Th2 cells tained this phenotype in long-term culture, producing
could develop in vivo in the absence of a non-T cell nearly normal Th2 levels of IL-4. In contrast, the early
source of IL-4 (Schmitz et al., 1994), but we could not non-IL-4-producing Stat6-deficient T cells remained
distinguish if this was due to autonomous IL-4 produc- negative. Surprisingly, the IL-4-producing Stat6-defi-
tion or to an unknown Th2-inducing factor. In analyzing cient T cells expressed high levels of GATA-3, previously
T cell development in vitro, we observed a significant thought to be induced only by IL-4 through Stat6,
number of Stat6-deficient T cells produced IL-4 on day whereas non-IL-4-producing Stat6-deficient T cells lacked
6 after primary activation (Figure 1). Although lower than GATA-3, as expected. This result suggests GATA-3 ex-
wild-type Th2 cultures, IL-4-producing cells were signifi- pression can be augmented independently of Stat6 and
cantly more frequent in Stat6-deficient T cells than in IL-4 and can direct Th2 development independently of
wild-type or Stat6-deficient Th1 cultures. To analyze Stat6 and IL-4.
this phenomenon, we used the cellular affinity matrix Here we uncovered an important autoactivation path-
technology (Manz et al., 1995; Assenmacher et al., 1998). way that regulates Th2 commitment. In controls for ret-
roviral GATA-3, we noted unexpected induction of theWe modified this technology for sensitive detection
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antibodies have been previously described (Ouyang et al., 1998).endogenous GATA-3 gene. Had this induction occurred
Monoclonal anti-mIFNg (H22) was obtained from Dr. R. D. Schreiber.only in wild-type T cells, it may have been caused by
secreted IL-4 and acted by an extracellular pathway to
T Cell Activation and Phenotype Differentiationinduce endogenous GATA-3 via Stat6 (Ouyang et al.,
Splenocytes from DO11.10 TCR-transgenic wild-type or Stat6-defi-1998). However, we also observed induction of endoge-
cient mice were purified on a discontinuous density gradient (Histo-nous GATA-3 in IL-4-deficient and anti-IL-4-treated
paque-1119, Sigma) and activated by 0.3 mM chick ovalbumin pep-
Stat6-deficient T cells where this pathway of GATA-3 tide 323±339 (OVA) at 3 3 106 cells/ml in IMDM media. Naive T cells
induction is absent (Ouyang et al., 1998). The simplest were purified from splenocytes by cell sorting (Cytomation) after
interpretation is that there is a positive autoactivation staining splenocytes with APC-anti-CD4 and PE-Mel-14 (Guler et
al., 1996), and then activated by OVA peptide and irradiated BALB/cpathway, where GATA-3, either directly or indirectly,
splenocytes as APC (2000 rad, 2.5 3 106 cells/ml). IL-12 (10 U/ml)activates its own expression. We suggest that this find-
and anti-IL-4 (11B11, 10 mg/ml) were added for Th1 development,ing is significant for generating stability of T helper com-
and IL-4 (100 U/ml), anti-IFNg (10 mg/ml), and anti-IL-12 (Tosh, 3
mitment.
mg/ml) were added for Th2 development. For passage, T cells were
In embryonic development, autoactivation of tran- harvested 7 days after the last activation, washed, and stimulated with
scription factors is a recognized mechanism contribut- OVA peptide (0.3 mM) at 1.25 3 105 cell/ml with irradiated BALB/c
splenocytes (2000 rad, 2.5 3 106 cells/ml) and with the addition ofing to cell fate determination. For example, in pituitary
the indicated cytokines. For ELISA, supernatants were collecteddevelopment, the differentiation of four distinct ventral
after 48 hr and measured as described (Hsieh et al., 1993). For anti-pituitary cell types relies upon interactions between the
CD3 stimulation, 5 mg/ml anti-CD3 antibody (500A2) in PBS was
transcription factors Pit-1 and GATA-2 (Dasen et al., coated overnight onto 48-well plates (1 ml/well) at 48C and washed
1999). Initially, dorsally expressed FGF8 induces Pit-1 twice with PBS, and T cells were applied (2.5 3 105 cells/ml) with
expression, which subsequently acts not only to repress cytokines as indicated in the figure legends.
GATA-2 expression, but also to augment and maintain
its own expression through autoregulation (Rhodes et IL-4 Secretion Assay for Cytometric Identification of Live
al., 1993; Dasen et al., 1999). Positive autoactivation IL-4-Secreting Cells
Splenocytes from wild-type (WT) or Stat6-deficient (2/2) DO11.10appears to be a general mechanism for stabilizing pat-
TCR-transgenic mice were stimulated at 2 3 106/ml with OVA pep-terns of gene expression developing from transient gra-
tide in the presence of IL-4, anti-IL-12, and anti-IFNg for 6±7 daysdients of signaling molecules. Thus, our demonstration
as indicated. Cells were then restimulated either using OVA and
that GATA-3 exhibits positive autoactivation fits well into APC in a T cell:APC ratio of 1:4 at 5 3 106/ml or using PMA (50 ng/
a recognized pattern of mechanisms for maintaining cell ml) and ionomycin (1 mM) at 2 3 106/ml. After 2.5 hr of restimulation,
fate commitment. cells were harvested, washed, and IL-4 bound to the IL-4R was
blocked with unconjugated anti-IL-4 mAb (BVD6±24G2, 400 mg/ml)This study suggests several modifications to our un-
(Sander et al., 1993) in PBS with 0.5% BSA (PBS/BSA) for 5 min atderstanding of Th2 development. First, the key action
48C. The cells were washed and labeled for 5 min at 48C with an IL-of IL-4 and Stat6 in Th2 development may be to induce
4-specific high-affinity capture matrix, i.e., a bispecific antibody±
the early expression of GATA-3. GATA-3, with the partic- antibody conjugate (Brosterhus et al., 1999) consisting of the anti-
ipation of other transcription factors such as c-Maf, is CD45 mAb 30-F11 (Ledbetter and Herzenberg, 1979) coupled to the
then capable of inducing, independently of Stat6, all anti-IL 4 mAb BVD4±1D11 (Abrams et al., 1992) (30±50 mg/ml, Mil-
tenyi Biotec). The cells were then transferred into 378C warm mediumfeatures of Th2 development, including expression of
at 2 3 105/ml and permitted to secrete cytokines at 378C for 15±30Th2-specific cytokines and transcription factors, inhibi-
min as indicated. Cells were then washed and captured IL-4 wastion of IFNg production, and Th2-specific chromatin re-
detected by staining with a second anti-IL-4 mAb (BVD6±24G2)
modeling. Second, we identified a pathway of GATA-3 conjugated to PE (3 mg/ml, Miltenyi Biotec) for 10 min at 48C. To
autoactivation that provides an IL-4-independent mo- control that, all cells, including APC, had a functional IL-4-specific
lecular basis for stabilized Th2 commitment. Third, the capture matrix on their cell surface. In all assays, an aliquot of the
cells labeled with the capture matrix was incubated with recombi-results show that conventional T cells may be capable
nant IL-4 (150 ng/ml) for 10 min at 48C. Cells were then washed andof providing an early source of IL-4 in addition to the
the added exogenous IL-4 bound to the capture matrix was detectedpreviously suggested populations such as NK1.11CD41
with anti-IL-4-PE as described above (Figure 2A, high control). To
T cells or mast cells. Moreover, we show in this report determine the background of the staining for secreted IL-4, another
that this early, IL-4-independent production of IL-4 by aliquot of the cells labeled with the capture matrix was transferred
naive T cells can be inhibited by IL-12. This suggests into ice-cold PBS/BSA to prevent secretion of cytokines. After 15
min on ice, cells were stained for secreted IL-4 with anti-IL-4-PE asthat naive T cells may be able to provide their own
described above (Figure 2A, low control). For FACS analysis, ali-source of initial IL-4 as long as there is no repression of
quots of all three samples were further stained with anti-CD4-FITCTh2 development by pathogen-directed APC activation.
or -APC (PharMingen) and/or anti-OVA-TCR-Cy5 mAb (KJ1-26).Finally, there is IL-4- and Stat6-independent GATA-3
Dead cells were excluded from analysis by gating on live lympho-
expression, although whether this is by a stochastic or cytes by forward and side scatter and exclusion of propidium iodide-
regulated process is not yet clear. For example, such binding particles (0.3 mg/ml). Samples were analyzed on a FACSCali-
alternative regulation of GATA-3 could be important in bur using CellQuest software (Becton Dickinson).
the IL-4-independent Th2 development that is directed
by DC2 cells (Rissoan et al., 1999). Further analysis of Correlation of the Staining of Secreted IL-4
these events will be an important next step in this area. and Intracellular IL-4
To compare staining of secreted IL-4 with intracellular IL-4 content,
immediately after the IL-4 secretion assay, an aliquot of cells wasExperimental Procedures
fixed in 2% formaldehyde in PBS for 15 min at room temperature
(RT). Cells were then washed and stained with KJ1-26 and a digoxi-Mice, Cytokines, and Antibodies
genized third anti-IL-4 mAb (11B11, 1 mg/ml) for 15 min at RT. AfterDO11.10 TCR-transgenic Stat6-deficient mice were provided by Dr.
M. J. Grusby (Kaplan et al., 1996b). Recombinant cytokines and washing, the digoxigenin (Dig)-coupled anti-IL-4 mAb was detected
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